Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs SnagRx

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and SnagRx head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 210 · Grade C

SnagRx

Visit SnagRx Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 65 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make SnagRx a bad call — it's best for readers who want compounded semaglutide and tirzepatide at a flat lifetime price. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
48
Supply Reliability
95
76
Transparency
90
72
Access Breadth
93
50
Clinical Oversight
92
76
Track Record
88
78
CoreAge RxBrief Score 94 · 65SnagRx

Price, coverage & the tracker

CoreAge RxSnagRx
Brief Score94/100 (A)65/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$69/mo on the Summer Start discount (list $299); month-to-month, no contract, flat at every dose, compounded

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$119/mo on the Summer Start discount (list $399); month-to-month, no contract, flat at every dose, compounded

CoverageUS only; restrictions by state, confirmed at intakeAll 50 states plus Washington D.C. (per Terms)
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableFallingprice falling

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

SnagRx: The advertised $69 semaglutide and $119 tirzepatide offers use a Summer Start Discount against $299/$399 list prices. The provider describes month-to-month billing and a lifetime price lock; confirm the applicable offer and renewal terms.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.